Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays

Mostrar otras versiones (1)

The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is a commonly used antigen for serology assays critical to determining the extent of SARS-CoV-2 exposure in the population. Different versions of the RBD protein have been developed and utilized in assays, with higher sensitivity attr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehalko, Jennifer, Drew, Matthew, Snead, Kelly, Denson, John-Paul, Wall, Vanessa, Taylor, Troy, Sadtler, Kaitlyn, Messing, Simon, Gillette, William, Esposito, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687410/
https://www.ncbi.nlm.nih.gov/pubmed/33248226
http://dx.doi.org/10.1016/j.pep.2020.105802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687410/
https://www.ncbi.nlm.nih.gov/pubmed/33248226
http://dx.doi.org/10.1016/j.pep.2020.105802

Ejemplares similares